Bone Health Flashcards

1
Q

How is osteoporosis characterised?

A

A progressive skeletal systemic disease:

  • Low bone mass
  • Micro architectural deterioration of bone tissue
  • Result in bone fragility and increased susceptibility to fracture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is osteoporosis defined?

A

A BMD of 2.5 standard deviations (T=2.5) or less when compared to that of healthy young adults of the same sex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are risk factors for osteoporosis?

A
  • Post menopausal women
  • Low BMI elderly
  • Smokers
  • Use of corticosteroids
  • Rheumatoid arthritis
  • Diabetes
  • FH of hip fractures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 2 primary functions of bone remodelling?

A
  1. Repair micro damage within skeleton to maintain strength

2. Supply calcium from the skeleton to maintain serum calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the hormone levels in primary hyperparathyroidism?

A

Calcium - high
PTH - high
Phosphate - low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the hormone levels in secondary hyperparathyroidism?

A

Calcium - low/normal
PTH - high
Phosphate - high/normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the hormone levels in tertiary hyperparathyroidism?

A

Calcium - high
PTH - really high
Phosphate - high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do you identify at risk patients?

A
  • Calculate FRAX score
  • Routine bloods including TFTs, calcium, vit D (PTH + myeloma screen if indicated)
  • Refer to NOGG based on FRAX - lifestyle advice + reassure, BMD or treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do you measure BMD?

A

DEXA scan
A defined wavelength of energy is passed through the area and through complex mathematical equations give us the density:
- Measures the mineral content of bone
- Low energy radiation
- Shorter scan times
- Accurate
- Focus on trabecular bone which has high metabolic activity and bone loss quickest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why is BMD low sensitivity?

A

Fragility fractures will occur in women who do not have osteoporosis as defined by a T score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Other than BMD how else is osteoporosis diagnosed?

A
  • Spine/hip# in the absence of major trauma

- Fractures of other sites (pelvis, humerus, wrist) + presence of low BMD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What markers are used for fracture risk?

A

CTX - bone resorption
P1NP - bone formation
- Predict fracture risk independent of BMD
- Predict fracture risk reduction when starting Rx
- Provide a marker for assessing compliance
- Use to decide on a drug holiday

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are non-pharmacological measures of osteoporosis?

A

Stop smoking

Exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What needs to be replaced before pharmacological therapy in osteoporosis?

A

If Vit D level low, load with cholecalciferol 40,000 units once a week for 7 weeks before starting Adcal D3.
VitD needs to be replaced before bisphosphonates are started.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the 1st line treatment in osteoporosis?

A

Bisphosphonates regulate osteoclast function - advise 3-5yrs treatment

  • Alendronate is 1st line, all patients need regular vitD
  • Rare SEs: osteonecrosis of jaw, atypical fractures of femur
  • 2nd line: zolendronic acid and denosumab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is mechanism of denosumab?

A
  • Twice yearly by SC administration
  • Increase BMD in the spine, hip and forearm
  • Binds to RANKL, inhibiting osteoclast maturation, reducing osteoclast survival
17
Q

What is denosumab approved for?

A
  • High risk of osteoporotic fractures
  • Failed or intolerant to other osteoporosis therapy
  • Men at high risk, men with prostate cancer on GnRH agonist therapy
  • Women with breast cancer on aromatise inhibitor therapy
  • Patients with a creatinine clearance <35 >20
18
Q

What is the dosage of PTH (teriparatide)?

A

Used if sustained minimum 3 fractures + T < 3.5
Daily SC injection given for max 2yrs
Reduced:
- Vertebral fractures by 65%, non-vertebral by 45%
Mono therapy, followed by antiresorptive agent
SEs: leg cramps, muscle pain, weakness, dizziness, headache and nausea

19
Q

How do you assess if the patient should stop bisphosphonates?

A

People at increased risk of fractures should continue, this includes:

  • Previous hip or vertebral fracture
  • 1 or more low trauma fractures during treatment
  • On current oral glucocorticoids of 7.5mg or more prednisolone/day or equivalent
  • Age >75yrs
  • T score on DEXA scan
20
Q

How do you interpret DEXA scan scores?

A
  • Above -1 SD is normal
  • -1 to -2.5 is mildly reduced BMD
  • < -2.5 is osteoporotic
  • > -2.5 can have a treatment holiday with reassessment of fracture risk and BMD after 2 years.